Type II topoisomerases as targets for rational drug design

被引：0
|
作者：
Laponogov, Ivan [1 ,2 ]
Veselkov, Dennis A. [1 ]
Umrekar, Trishant [1 ]
Crevel, Isabelle M-T. [2 ]
Pan, Xiao-Su [2 ]
Selvarajah, Jogitha [2 ]
Fisher, L. Mark [2 ]
Sanderson, Mark R. [1 ]
机构：
[1] Kings Coll London, Div Med & Life Sci, Randall Div Cell & Mol Biophys, London SE1 1UL, England
[2] Univ London, Div Biomed Sci, London SW17 0RE, England
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
380
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [1] Type II topoisomerases as targets for rational drug design
    Laponogov, I.
    Veselkov, D.
    Umrekar, T.
    Crevel, I.
    Pan, X.
    Fisher, L.
    Sanderson, M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C713 - C713
  • [2] MULTIDRUG RESISTANCE ASSOCIATED WITH ALTERED TOPOISOMERASE-II ACTIVITY - TOPOISOMERASES-II AS TARGETS FOR RATIONAL DRUG DESIGN
    MORROW, CS
    COWAN, KH
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (08) : 638 - 639
  • [3] Type II DNA topoisomerases as antibacterial targets
    Shen, LL
    Chu, DTW
    CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (02) : 195 - 208
  • [4] Type II and IB DNA topoisomerases as targets of anthracyclines
    Capranico, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U229 - U230
  • [5] Drug targeting of Type II topoisomerases across species
    Laponogov, Ivan
    Pan, Xiao-Su
    Veselkov, Dennis A.
    Umrekar, Trishant
    Crevel, Isabelle M. -T.
    Selvarajah, Jogitha
    Magrioti, Dimitra
    Fisher, L. Mark
    Sanderson, Mark R.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S59 - S59
  • [6] Granzymes as potential targets for rational drug design
    Weston, GS
    Sindelar, RD
    CURRENT MEDICINAL CHEMISTRY, 1996, 3 (01) : 37 - 46
  • [7] Ungeremine effectively targets mammalian as well as bacterial type I and type II topoisomerases
    Casu, Laura
    Cottiglia, Filippo
    Leonti, Marco
    De Logu, Alessandro
    Agus, Emanuela
    Tse-Dinh, Yuk-Ching
    Lombardo, Valentina
    Sissi, Claudia
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (23) : 7041 - 7044
  • [8] DNA TOPOISOMERASES AS TARGETS FOR NEW DRUG DEVELOPMENT
    ROSS, WE
    MACDONALD, TL
    HERTZBERG, RP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 534 - 535
  • [9] Type II DNA topoisomerases
    Berger, JM
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 1998, 8 (01) : 26 - 32
  • [10] BigEndothelin isoforms: Molecular models as targets for rational drug design
    Peto, H
    Janes, RW
    Wallace, BA
    BIOPHYSICAL JOURNAL, 1998, 74 (02) : A255 - A255
12345